Serum Albumin/Globulin Ratio and Cognitive Function in Americans: A Linear Association
1Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Background:
Nutritional status and chronic inflammation play crucial roles in cognitive impairment. The albumin-globulin ratio (AGR) serves as a biomarker for assessing nutrition and inflammation; however, its relationship with cognitive function remains unclear. The objective of this study is to investigate the correlation between them.
Methods:
The present study utilized data obtained from the National Health and Nutrition Examination Surveys conducted during the years 2001-2002 and 2011-2014. The relationships between the AGR and cognitive impairment were assessed through the application of weighted logistic regression analysis, smoothed fitted curves, the investigation of threshold effects, and the execution of subgroup analysis. In this study, participants with lower AGR values had a greater incidence of cognitive impairment.
Results:
The results of the logistical regression model, following adjustments for all potential influencing factors, demonstrated that the AGR may be associated with an increased incidence of cognitive impairment (OR: 0.550, 95% CI: 0.359, 0.843). This finding indicates that for each unit increase in the AGR within the fourth quartile, the prevalence of cognitive impairment decreased by 45%. Smoothed fitted curves and threshold effects demonstrated a linear relationship between the AGR and cognitive impairment (OR: 0.448, 95% CI: 0.312, 0.642). Subgroup analysis revealed that the association between the AGR and cognitive impairment was not influenced by factors such as gender, education, or hyperlipidemia.
Conclusions:
Having a lower AGR may be linked to a higher risk of cognitive impairment.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Related Concept Videos
Cognitive Development During Adulthood
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Serum Studies: Renal Function Tests
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
